Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2002
06/13/2002DE10041671C1 Verfahren zur Herstellung von Imidazo[1,2-c][2,3]benzodiazepinen sowie Phenylessigsäureester und Oxazol-Derivate als Zwischenprodukte bei deren Herstellung Benzodiazepines process for the preparation of imidazo [1,2-c] [2,3] oxazole and phenylacetic acid esters and derivatives, as intermediates in the preparation thereof
06/13/2002CA2436916A1 Use of pyrazolo[4,3-d]pyrimidines
06/13/2002CA2435467A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands
06/13/2002CA2431187A1 Macroheterocylic compounds useful as kinase inhibitors
06/13/2002CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002CA2429728A1 Tyrosine kinase inhibitors
06/12/2002EP1213289A1 N-benzenesulfonyl L-proline compounds as bradykinin antagonists
06/12/2002EP1212384A1 Selectively light-absorptive material, coating composition containing the same, and filter manufactured using the coating composition for color displays
06/12/2002EP1212327A2 Pyrazolopyrimidines as therapeutic agents
06/12/2002EP1212326A1 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS
06/12/2002EP1212325A2 A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
06/12/2002EP1212324A1 Imidazo-triazine derivatives as ligands for gaba receptors
06/12/2002EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/12/2002EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
06/12/2002EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents
06/12/2002EP1211940A1 Azabicyclo and azacyclo oxime and amine compounds as pesticides
06/12/2002EP0984778B1 Neuropeptide-y ligands
06/12/2002EP0888354B1 Process for producing radiolabelled benzodiazepine receptor agents and composition containing the same
06/12/2002EP0885221B1 Azabicyclic esters of carbamic acids useful in therapy
06/12/2002CN1353714A Triazolopyrimidinol compounds and salts thereof
06/12/2002CN1353702A Adamantane derivatives
06/12/2002CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds
06/12/2002CN1353606A IL-8 receptor antagonists
06/11/2002US6403807 Bridged fluorescent dyes, their preparation and their use in assays
06/11/2002US6403790 Suspending and dissolving epinastine base in water by adding aqueous hydrochloric acid at specified ph, extracting solution obtained with organic water-immiscible solvent, removing solvent, adjusting ph to precipitate product, drying
06/11/2002US6403788 Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
06/11/2002US6403632 Cyclic amide derivative
06/11/2002US6403608 3-Substituted isoquinolin-1-yl derivatives
06/11/2002US6403592 Serotonin reuptake inhibitors
06/11/2002US6403591 1-azatricyclic-4-benzylpiperazines
06/11/2002US6403588 Imidazopyridine derivatives
06/11/2002CA2169838C Antipsychotic method
06/06/2002WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
06/06/2002WO2002044182A1 Condensed purine derivatives as a1 adenosine receptor antagonists
06/06/2002WO2002044180A1 Lactam compounds and medicinal use thereof
06/06/2002WO2002044179A1 1,4,5,6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof
06/06/2002WO2002044168A2 Indole-type inhibitors of p38 kinase
06/06/2002WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
06/06/2002WO2002012242A3 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/06/2002WO2001093841A3 Barbituric acid analogs as therapeutic agents
06/06/2002US20020068827 Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonists
06/06/2002US20020068748 Diazabicyclooctane derivatives and therapeutic uses thereof
06/06/2002US20020068746 Pyrrolo[2,3-d]pyrimidine compounds
06/06/2002US20020068744 Interacting with tubulin and microtubules and promoting microtubule polymerization
06/06/2002US20020068740 Treatment of diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, myocardial infarction, cataracts and diabetic cardiomyopathy.
06/06/2002US20020068734 Nitrogen-containing heterocyclic compounds
06/06/2002US20020068721 Purine derivatives
06/06/2002US20020068705 Sugar derivatives of indolocarbazoles; exhibit topoisomerase-I activity
06/06/2002DE10060388A1 Verwendung von Pyrazolo [4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines
06/06/2002CA2429382A1 Indole-type inhibitors of p38 kinase
06/06/2002CA2425892A1 1,4,5,6-tetrahydroimidazo[4,5-d]diazepine derivative or salt thereof
06/05/2002EP1211313A2 Modulation of PDE11A activity
06/05/2002EP1210714A2 High density non-volatile memory device
06/05/2002EP1210349A2 PYRAZOLO 4,3-d]PYRIMIDINES
06/05/2002EP1210333A2 Novel herbicides
06/05/2002EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands
06/05/2002EP0788501B1 Protein kinase inhibitors for treatment of neurological disorders
06/05/2002EP0642516B1 Macrocyclic immunomodulators
06/05/2002CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV
06/04/2002US6399785 Multiply-substituted fullerenes
06/04/2002US6399780 Kinase inhibitors; anticancer agents
06/04/2002US6399769 Reacting formylbenzenesulfonic acid and pyrrole; heating
06/04/2002US6399768 Recording
06/04/2002US6399621 N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
06/04/2002US6399609 Corticotropin releasing factor (crf) antagonists
06/04/2002US6399608 Fluoxetine, paroxetine or sertraline with 1,2,4-triazolo (4,3-b)pyridazine derivative; nonsedating anxiolytic modulator of benzodiazepine binding site of gamma amino-butyric acid receptor; central nervous system
06/04/2002US6399598 Diheterocyclic metalloprotease inhibitors
06/04/2002US6399597 1,8-naphthosultamylmethyl carbapenem antibacterial compounds, compositions containing such compounds and methods treatment
05/2002
05/30/2002WO2002042306A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/30/2002WO2002042305A1 Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition
05/30/2002WO2002042304A2 Cyclopenta[b][1,4] diazepino[6,7,1-hi]indoles as 5ht2c antagonists
05/30/2002WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
05/30/2002WO2002041880A2 Use of pyrazolo[4,3-d]pyrimidines
05/30/2002WO2002020526A3 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
05/30/2002WO2001085686A3 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
05/30/2002WO2001046194A3 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives
05/30/2002US20020065416 Anti-inflammatory agents
05/30/2002US20020065414 Quarternary ammonium salt can act as phase-transfer catalyst to convert glycine derivatives into optically active alpha-amino acid derivatives by stereoselectively alkylating glycine derivatives
05/30/2002US20020065309 For therapy of sex-hormone related conditions, as contraceptives
05/30/2002US20020065292 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity
05/30/2002US20020065291 Amine salts of an integrin receptor antagonist
05/30/2002US20020065290 Used as corticotropin-releasing factor (CRF) antagonists, in therapy and diagnosis of stress related disorders such as post traumatic stress disorder (PTSD) as well as depression, headache and anxiety
05/30/2002US20020065284 Dipeptide derivatives
05/30/2002US20020065278 Non-imidazole aryloxyalkylamines
05/30/2002US20020065248 Pyrrolopyrazinones useful as serine protease inhibitors
05/30/2002CA2429645A1 Use of pyrazolo[4,3-d]pyrimidines
05/29/2002EP1208748A1 Organ preservatives
05/29/2002EP1208104A2 Tricyclic inhibitors of poly(adp-ribose) polymerases
05/29/2002EP1208103A2 Reverse-turn mimetics and methods relating thereto
05/29/2002EP1208102A1 Synthesis of substituted pyrazolopyrimidines
05/29/2002EP1084148A4 A catalyst that oxidizes steroids and other substrates with catalytic turnover
05/29/2002DE10058662A1 Verwendung von Pyrazolo[4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines
05/29/2002CN1351601A Heterocyclic compounds binding chemotactic factor receptor
05/29/2002CN1351498A Pyrrolotriazines inhibitors of kinases
05/29/2002CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors
05/29/2002CN1351014A Process for preparing chlorophyll zinc and its product
05/29/2002CN1351012A Process for extracting high-purity tea polyphenol, theapigment and theine
05/29/2002CN1085710C Structured pigment coating and its preparation and use
05/28/2002US6395810 Bicyclooctane derivatives as plasticizers
05/28/2002US6395809 Salt formation with hydrochloric, sulfuric, or phosphoric acid; automobiles, electronics